SEC 13F Intelligence

Yacktman Asset Management LP / CRC

Yacktman Asset Management LP’s Canadian Nat Res Ltd Med Ter Position

Does Yacktman Asset Management LP own Canadian Nat Res Ltd Med Ter (CRC)? Yes16.54M shares worth $806M (+10.75% of its 13F portfolio) as of Q1 2026, down from 18.78M shares the prior filed quarter.

Position Value
$806M
Q1 2026
Shares
16.54M
% of Portfolio
+10.75%
Quarters Held
21
currently held

Position History CRC

Reported value by quarter
Q1 ’21: $207MQ1 ’21Q2 ’21: $463MQ3 ’21: $608MQ4 ’21: $719MQ4 ’21Q1 ’22: $1.1BQ2 ’22: $907MQ3 ’22: $736MQ3 ’22Q4 ’22: $843MQ1 ’23: $842MQ2 ’23: $850MQ2 ’23Q3 ’23: $975MQ4 ’23: $978MQ1 ’24: $1.1BQ1 ’24Q2 ’24: $1.0BQ3 ’24: $963MQ4 ’24: $893MQ4 ’24Q1 ’25: $840MQ2 ’25: $695MQ3 ’25: $668MQ3 ’25Q4 ’25: $636MQ1 ’26: $806Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202616.54M$806M+10.75%
Q4 202518.78M$636M+8.90%
Q3 202520.91M$668M+9.21%
Q2 202522.13M$695M+9.33%
Q1 202527.27M$840M+11.04%
Q4 202428.93M$893M+10.44%
Q3 202429.01M$963M+9.88%
Q2 202429.46M$1.0B+9.84%
Q1 202415.04M$1.1B+10.32%
Q4 202314.93M$978M+9.10%
Q3 202315.08M$975M+9.61%
Q2 202315.11M$850M+8.06%
Q1 202315.21M$842M+8.33%
Q4 202215.17M$843M+8.39%
Q3 202215.81M$736M+8.02%
Q2 202216.89M$907M+9.41%
Q1 202216.95M$1.1B+9.38%
Q4 202117.03M$719M+6.41%
Q3 202116.64M$608M+5.85%
Q2 202112.77M$463M+4.50%
Q1 20216.70M$207M+2.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Yacktman Asset Management LP’s full portfolio or all institutional holders of CRC.